Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
Autor(es) y otros:
Fecha de publicación:
2018
Versión del editor:
Citación:
Nature, 554(7690), p. 62-68 (2018); doi:10.1038/nature25459
Descripción física:
p. 62-68
ISSN:
DOI:
Patrocinado por:
We thank the comparative experimental pathology team for discussions, and A. Selmeier, L. Dajka, O. Seelbach, P. Meyer, T. Schmidt, J. Eichinger and T. Stauber for technical assistance as well as M. Reichert for vector constructs. The work was supported by the German Cancer Consortium Joint Funding Program, the Helmholtz Gemeinschaft (PCCC Consortium), the German Research Foundation (SFB1243; A13/A14) and the European Research Council (ERC CoG number 648521).
Colecciones
- Artículos [36472]